Background: Congenital adrenal hyperplasia (CAH) is one of the most common autosomal recessive inherited endocrine diseases. Steroid 11b-hydroxylase (P450c11) deficiency (11OHD) is the second most common form of CAH. Aim: The aim of the study was to study the functional consequences of three novel CYP11B1 gene mutations (p.His125Thrfs*8, p.Leu463_Leu464dup and p.Ser150Leu) detected in patients suffering from 11OHD and to correlate this data with the clinical phenotype. Methods: Functional analyses were done by using a HEK293 cell in vitro expression system comparing WT with mutant P450c11 activity. Mutant proteins were examined in silico to study their effect on the three-dimensional structure of the protein.
Introduction
Congenital adrenal hyperplasia (CAH), one of the most common autosomal recessive inherited endocrine diseases, is characterised by complete or partial impairment of adrenal steroidogenesis (1, 2) . Although over 90% of cases of CAH are caused by 21-hydroxylase cortisol synthesis caused by mutations in the CYP11B1 gene coding for 11b-hydroxylase (6, 7, 8, 9) . An impairment of 11b-hydroxylase activity leads to an accumulation of the precursor steroids, which are shunted into the adrenal androgen synthesis pathway, resulting in prenatal virilisation of female external genitalia (46,XX disorder of sex development). Moreover, the excess of postnatal androgen causes androgenisation and rapid somatic growth as well as accelerated bone maturation in both sexes. The accumulation of DOC, which binds to and activates the mineralocorticoid receptor, leads to hypertension in about two-thirds of all patients (3, 10, 11, 12, 13) . Hormonal diagnosis of 11OHD is verified by elevated baseline concentrations of DOC and S in classical forms as well as increased response to cosyntropin stimulation in non-classic forms (14) .
The non-classic 11OHD form is caused by partial impairment of the P450c11 function (10, 15) with a phenotype resembling non-classic 21-hydroxylase deficiency (11) . Non-classic 11OHD can manifest with mild virilisation and precocious pseudopuberty in children. Female patients with non-classic 11OHD are born with normal external genitalia and may have hirsutism and oligomenorrhea in adulthood, resembling signs and symptoms suggestive for polycystic ovary syndrome. However, only a minor percentage of women with hirsutism and oligomenorrhea suffer from non-classic 11OHD (10) . Unlike in classic 11OHD, arterial hypertension is not commonly found.
In the current study, three novel CYP11B1 mutations detected in three patients with classic and in one patient with non-classic 11OHD were studied in order to describe the effect of these variants.
Subjects and methods

Patient 1
A male patient (karyotype 46,XY) of Turkish origin was referred to the Paediatric Endocrinology Department at Erciyes University, Kayseri, Turkey at the age of 2 years with the complaint of penile growth. His parents are first cousins and he has three siblings, one of them also suffering from 11OHD (patient 2). Results of the initial physical examination were as follows: height 97 cm (C3.1 SDS) (16), weight 17 kg, BMI 18 kg/m 2 (C1.07 SDS) (17) , blood pressure 100/70 mmHg (90th percentile) (18), testicular volume 3 ml, penile length 9 cm (C5.3 SDS) (19) , advanced bone age of 7 years and dark skin pigmentation especially at the genitalia. Abdominal ultrasound examination revealed hyperplasic adrenal glands. Steroid hormone analyses supported the diagnosis of 11OHD (Table 1) . Hydrocortisone supplementation was initiated. During his last visit at 14 years of age, physical examination revealed the (20) and 65 kg, respectively, and his BMI was 28 kg/m 2 (C0.11 SDS) (17) . Hormonal data at 27 years of age is shown in Table 1 .
Blood pressure was not taken on that occasion. Computed tomography scan of adrenal glands revealed nodular thickening. Semen analysis revealed severe oligospermia and mild-to-moderate asthenozoospermia. Folliclestimulating hormone and luteinising hormone levels were elevated with 17 mIU/ml (reference range 1.5-12.4) and 10 mIU/ml (1.7-8.6) respectively. Scrotal ultrasonography revealed two heterogeneous hypoechogenic lesions (right testis, 38!20 mm and left testis, 24! 155 mm) with lobulated contours and irregular boundaries reflecting testicular adrenal rest tumours (TART). The TART located on right testis was removed by testis sparing surgery. Histological examination was compatible with TART ( Fig. 1 ). Prednisolone therapy was resumed and the patient's wife gave birth to a female child. The patient's fertility was not investigated in detail as he refused to perform a semen analysis.
Patient 4
The female patient (karyotype 46,XX) of Moroccan descent was diagnosed at the Paediatric Endocrinology unit at the Children's Hospital Altona, Hamburg, Germany, as non-classical 11OHD when she was 5.5 years old and came to attention with premature 
Sequence analysis of the CYP11B1 gene
The molecular analysis of the CYP11B1 gene was carried out after receiving informed consent from patients and/or legal guardian for genetic studies. Genomic DNA was prepared from peripheral blood leukocytes and amplification of exons 1-9 of the CYP11B1 gene was carried out as described previously (22, 23) . Direct DNA sequencing and analysis of the coding region of the CYP11B1 gene was done as described previously (23) . Sequence variants were designated according to the recommendations of the Human Genome Variation Society (www.hgvs.org/ rec.html) using the GenBank reference sequences NC_000008.10 (CYP11B1 g.DNA), NM_000497 (CYP11B1 c.DNA) and NP_000488.3 (CYP11B1 p.protein).
Transient transfection assay
Each mutation was introduced into a CYP11B1-pcDNA3.1 expression vector construct (kindly provided by Prof. R Bernhardt, Institute of Biochemistry, University des Saarlandes, Saarbrücken, Germany) by site-directed mutagenesis as described previously (24, 25) . In vitro transient transfection assay was performed in triplicates using the HEK293 cell line thrice. The cells were transfected with each pcDNA3.1-CYP11B1 mutant constructs with additional transfection of adrenodoxin (pECE-ADX), Adx reductase (pECE-ADR) expression vectors (kindly provided by Prof. W L Miller, Department of Pediatrics, University of California, San Francisco, CA, USA) and pRK-TK (Promega) coding for Renilla luciferase as it was described in our previous paper (25) . The kinetic constants of CYP11B1 in intact HEK293 cells were determined 48 h after transfection. The cells were incubated in triplicates for 270 min at 37 8C with 1 ml DMEM medium containing 0.1, 0.25, 0.5, 1, 2, and 4 mmol/l DOC and S in parallel with 10 mM NADPH (Sigma-Aldrich). The steroid hormones DOC, B, S and F were simultaneously determined in the cell culture supernatant using an UPLC-MS/MS method as described previously (25, 26, 27) . Western blot analysis was carried out to ensure the expression and translation of WT and mutant proteins as described previously (24, 25, 28) .
All assays were performed in at least three independent triplicate experiments, and data are presented as meanGS.D. Kinetic parameters were established by nonlinear regression using the Michaelis-Menten equation to determine the Michaelis-Menten constant (K m ) and maximum velocity (V max ). Catalytic efficiency was defined as the ratio V max /K m expressed as percentage of WT. The 11-hydroxylase activity of the mutants was expressed as a percentage of substrate conversion in picomole per milligram of total protein per minute, defining CYP11B1 WT activity as 100% after correction for total protein with Renilla luciferase activity. Enzyme kinetic parameters and enzymatic activity were calculated using the GraphPad Prism Software, version 5.0 (GraphPad, Inc., San Diego, CA, USA).
Molecular modelling
We used a fold recognition algorithm to show that the human CYP11B1 sequence is compatible with the architecture of the enzyme family (ProHit package, ProCeryon Biosciences GmbH, Salzburg, Austria). The template structure with the highest score of the pair potential was the X-ray structure of the cytochrome CYP11A1 (PDB accession code: 3MZS) and served as the template for the three-dimensional model of CYP11B1. According to the alignment obtained by the fold recognition procedure, amino acid residues were exchanged in the template. Insertions and deletions in CYP11B1 were modelled using a database search approach included in the software package WHATIF. The structural representation was generated with the Ribbons Software (Avatar Software AB, Stockholm, Sweden) as described previously (29) .
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Results
Sequence analysis of the CYP11B1 gene
Patient 1 showed a novel homozygous guanine deletion at cDNA position 372 (c.372delG) in exon 2 of the CYP11B1 gene, resulting in a frameshift and a premature stop codon (p.His125Thrfs*8). Patient 2 showed the identical homozygous deletion c.372delG. Parents were not available for analysis; therefore, a heterogeneous deletion of the CYP11B1 gene cannot be ruled out. Genetic analysis in patient 3 depicted a novel homozygous duplication of six bases in exon 8, c.1387_1392dupCTGCTG, causing a duplication of two leucines in frame p.Leu463_ Leu464dup. The CYP11B1 gene analysis revealed that patient 4 was compound heterozygous for the novel mutation c.372delG (p.His125Thrfs*8) inherited from the mother and the novel mutation c.449COT (p.Ser150Leu) located in exon 3 inherited from the father (Fig. 2 ).
In vitro functional 11-hydroxylase assays
The three novel CYP11B1 mutations were functionally analysed using transiently transfected HEK293 cells measuring the conversion of DOC to B and S to F. The two mutations detected in patients with 11OHD (p.His125Thrfs*8 and p.Leu463_Leu464dup) had no residual enzymatic activity. The mutation p.Ser150Leu detected with non-classic 11OHD showed only partial 11-hydroxylase impairment with a reduced activity of 19.2G1.4% (meanGS.D.) and 14.7G0.5% (meanGS.D.) for the conversion to B and F compared with WT respectively. Determination of kinetic constants showed similar K m values for both B and F production with significantly impaired V max compared with the WT (Fig. 3) .
Western blot analysis demonstrated that all mutations apart from the p.His125Thrfs*8 had translation efficiency similar to WT. The mutant p.His125Thrfs*8 was not detectable by western blotting either due to the loss of the antibody binding site or due to nonsense-mediated mRNA or protein decay ( Supplementary Fig. 1 , see section on supplementary data given at the end of this article).
Molecular modelling
The frameshift mutation p.His125Thrfs*8 terminates the translation at the B-C loop of the protein (30) . By this, all relevant enzyme structures including the substrate recognitions sides and haeme-binding sites are not present, resulting in a complete loss of function (31, 32) . The variation p.Leu463_Leu464dup is located in the amino terminal L-helix. Two leucines are inserted in a leucine-rich part of the L-helix carrying four leucines. The L-helix is involved in haeme binding as well as in interactions with redox partners (30) . The distal L-helix forms parts of the protein's surface. The residue p.Ser150 is located in the C-D loop connecting the C-helix with the D-helix (Fig. 4) .
Discussion
In the present study, we have functionally characterised three novel CYP11B1 mutations detected in three families. The p.Leu463_Leu464dup and p.Ser150Leu mutations were unique for the studied families. On the contrary, the p.His125Thrfs*8 mutation was detected in both Moroccan and Turkish families where there is no known relationship. Reported CYP11B1 mutations are p.Arg448Cys (33, 34) , p.Trp116Cys, p.Leu299Pro (2), p.Leu489Ser (15) , Glu338term (35) and p.Asn394 Argfs*74, p.Trp318Thr, p.Arg43Gln and Ala259Asp in the Turkish population IVS5C2TOG, p.Gly446Val (36) and p.Arg448Cys (22) in the Moroccan population. The elevated frequency of 11OHD in Morocco and Turkey is most likely due to the higher rate of consanguineous marriages producing an enrichment of recessively inherited diseases (37) . The prevalence of consanguinity in Morocco reported to date varies between 20-28 and 59.1% in patients suffering from autosomal recessive diseases (38) . In Turkey, around 20% of marriages are consanguineous (39) .
In vitro 11-hydroxylase activity of !5% can be considered severe and is most often associated with classic 11OHD (7, 24, 40) . The patients 1 and 2 carrying a completely inactivating mutation (p.His125Thrfs*8) of the CYP11B1 gene show a typical classical 11OHD phenotype with highly elevated steroids hormones, prenatal virilisation of the external genitalia in females and macrogenitosomia in males (5) . Neither patients showed obvious signs of hypertension. The latest clinical assessment revealed that hydrocortisone treatment with doses above the recommended has not been effective enough to normalise steroid hormone levels in either patient, most likely because of poor adherence to the treatment. This demonstrates the necessity for long-term follow-up of the patients by experienced physicians, which is obviously difficult in rural Turkey. The mutation p.His125Thrfs has a comparable effect on the protein structure and function with the mutant c.358-362dup usually regress with advancing age except in CAH patients in whom low levels of cortisol induce ACTH secretion and hyperplasia of dispersed adrenal tissue (43) . The presence of adrenal rests within the testes of adult males with classic 21-hydroxylase CAH is more frequent in the salt-wasting form and is associated with a higher risk for infertility (44) . 11OHD patients with TART are rare. Up to our knowledge, only nine cases are presented in the literature so far (43, 45, 46, 47, 48) . This is most likely due to the smaller incidence of CAH due to 11-hydroxylase deficiency. All reported cases were poorly compliant to treatment. However, the idea that poor control may lead to a higher risk of TART was just recently refuted in 21-hydroxylase deficiency (49, 50) . Therefore, the findings in 11OHD may be a collection bias. In the patient, the TART located in the right testis was removed because of its size and the difficulty to distinguish it from a Leydig cell tumour during follow-up (51) . TART cells showed eosinophilic cytoplasm with neither lipochrome pigments nor Reinke crystalloids ( Fig. 1) (47, 52) . The tumour on the left is under control with prednisolone treatment. Whether surgery has had a positive effect on the testicular function or whether resuming prednisolone treatment led to fertility remains unclear. TART surgery in 21-hydroxylase deficiency has no proven effect on fertility (53) . The variation p.Leu463_Leu464dup detected in patient 3 is located in the amino terminal L-helix. Two leucines are inserted in a leucine-rich part of the L-helix carrying four leucines. The L-helix is involved in haeme binding as well as in interactions with redox partners (30) . The distal L-helix forms parts of the protein's surface. As four residues are needed for a full helical turn, the addition of two residues will produce an additional half turn of the helix, leading to a displacement of the proximal part of the helix and disturbance of substrate binding and electron flux, or interference with the binding of redox partners due to changes in the protein surface. Both possibilities will result in a complete loss of function. Interestingly, Geley et al. described a patient with classic 11OHD, caused by a duplication of a single leucine at the identical position. This variant also caused a complete loss of 11-hydroxylase activity (7) .
Patient 4 showed clinical signs compatible with nonclassic CAH (25) . The novel mutation p.Ser150Leu detected in this patient had a residual activity of 19.2% of the WT. By this, it is comparable with the previously described mutations associated with non-classic 11OHD. Interestingly, only 12 mutations causing non-classic 11OHD have been described so far (8, 10, 25, 54) . This is most likely due to the overall rarity of 11OHD. However, the increasing number of reports on affected patients should increase the awareness for non-classic 11OHD. The residual activity of mutations associated with non-classic 11OHD ranged from 9 to 40% of WT activity, which is well comparable with the residual activity of mutations in the CYP21A2 gene causing non-classic 21-hydroxylase deficiency (55) . The residue p.Ser150 is located in the C-D loop connecting the C-helix with the D-helix of the CYP11B1 protein (Fig. 4) . This loop is located at the surface of the molecule. The change to p.Leu150 does not lead to obvious steric problems with neighbouring residues in silico. However, the exchange of the polar serine by the hydrophobic leucine leads to a change in the surface properties of the molecule. Since the adjacent D-helix is part of the redox partner interaction side, the mutation may induce a decrease in electron flux which is consistent with the observed reduction of V max (30, 32) .
In conclusion, we have shown the inactivating nature of two novel CYP11B1 mutations in classic 11OHD in addition to one variant with residual activity associated with non-classic 11OHD. The analyses of in vitro enzyme function broaden our understanding of CYP11B1 function relationships and help to counsel families as the severity of the clinical disease expression can be estimated. The condition of non-classic 11OHD is a rare disease but should not be missed in the differential diagnosis of hyperandrogenism.
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